Canada Life’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.79M Sell
59,820
-178
-0.3% -$18.3K 0.01% 684
2025
Q4
$6.37M Sell
59,998
-15,239
-20% -$1.77M 0.01% 656
2025
Q3
$9.47M Buy
75,237
+818
+1% +$97.4K 0.01% 576
2025
Q2
$9.13M Sell
74,419
-1,841
-2% -$210K 0.01% 575
2025
Q1
$7.73M Sell
76,260
-6,389
-8% -$624K 0.01% 624
2024
Q4
$7.63M Buy
82,649
+2,515
+3% +$247K 0.01% 649
2024
Q3
$7.75M Buy
80,134
+5,473
+7% +$492K 0.01% 658
2024
Q2
$6.4M Buy
74,661
+13,604
+22% +$1.14M 0.01% 699
2024
Q1
$5.04M Buy
61,057
+578
+1% +$42.3K 0.01% 807
2023
Q4
$4.03M Sell
60,479
-4,265
-7% -$276K 0.01% 876
2023
Q3
$4.35M Buy
64,744
+3,167
+5% +$218K 0.01% 796
2023
Q2
$4.17M Sell
61,577
-8,961
-13% -$562K 0.01% 810
2023
Q1
$3.82M Sell
70,538
-1,102
-2% -$64.1K 0.01% 886
2022
Q4
$4.29M Buy
71,640
+4,674
+7% +$254K 0.01% 821
2022
Q3
$3.03M Sell
66,966
-16,024
-19% -$802K 0.01% 930
2022
Q2
$3.7M Buy
82,990
+9,829
+13% +$504K 0.01% 821
2022
Q1
$4.26M Buy
73,161
+6,066
+9% +$317K 0.01% 825
2021
Q4
$3.49M Buy
67,095
+6,573
+11% +$339K 0.01% 894
2021
Q3
$3.64M Buy
60,522
+10,361
+21% +$652K 0.01% 818
2021
Q2
$3.11M Buy
50,161
+12
+0% +$800 0.01% 883
2021
Q1
$3.26M Sell
50,149
-21,239
-30% -$1.39M 0.01% 846
2020
Q4
$4.7M Sell
71,388
-20,707
-22% -$1.22M 0.01% 789
2020
Q3
$4.76M Sell
92,095
-3,035
-3% -$156K 0.01% 729
2020
Q2
$4.68M Sell
95,130
-1,685
-2% -$90.9K 0.01% 713
2020
Q1
$4.92M Sell
96,815
-3,711
-4% -$214K 0.01% 633
2019
Q4
$5.49M Sell
100,526
-1,648
-2% -$89.4K 0.01% 697
2019
Q3
$5.15M Sell
102,174
-12,106
-11% -$608K 0.01% 666
2019
Q2
$5.75M Sell
114,280
-6,622
-5% -$321K 0.01% 687
2019
Q1
$5.61M Buy
120,902
+48
+0% +$2.43K 0.01% 622
2018
Q4
$5.67M Buy
120,854
+22,997
+24% +$1.31M 0.02% 616
2018
Q3
$6.07M Buy
97,857
+5,651
+6% +$344K 0.01% 643
2018
Q2
$4.97M Buy
92,206
+2,440
+3% +$122K 0.01% 711
2018
Q1
$4.08M Buy
89,766
+19,945
+29% +$855K 0.01% 770
2017
Q4
$2.74M Sell
69,821
-2,514
-3% -$95.6K 0.01% 967
2017
Q3
$2.66M Buy
72,335
+5,381
+8% +$192K 0.01% 969
2017
Q2
$2.58M Buy
66,954
+2,014
+3% +$73.7K 0.01% 971
2017
Q1
$2.21M Buy
64,940
+1,204
+2% +$39.5K 0.01% 1063
2016
Q4
$2.09M Buy
63,736
+49,656
+353% +$1.61M 0.01% 1060
2016
Q3
$454K Hold
14,080
﹤0.01% 1690
2016
Q2
$433K Buy
14,080
+2,891
+26% +$90.4K ﹤0.01% 1689
2016
Q1
$335K Hold
11,189
﹤0.01% 1043
2015
Q4
$310K Hold
11,189
﹤0.01% 1060
2015
Q3
$342K Buy
11,189
+2,640
+31% +$91.9K ﹤0.01% 989
2015
Q2
$313K Hold
8,549
﹤0.01% 1153
2015
Q1
$301K Hold
8,549
﹤0.01% 1131
2014
Q4
$261K Hold
8,549
﹤0.01% 1175
2014
Q3
$252K Hold
8,549
﹤0.01% 1122
2014
Q2
$243K Hold
8,549
﹤0.01% 1051
2014
Q1
$243K Hold
8,549
﹤0.01% 1033
2013
Q4
$228K Buy
+8,549
New +$238K ﹤0.01% 1037

Other funds holding EHC

Canada Life's EHC Position: Q1 2026 in Review

Canada Life reduced its Encompass Health (EHC) stake by 0.3% in Q1 2026, selling an estimated $18.3K and leaving 59,820 shares worth $5.79M. The position accounts for 0.01% of the portfolio, ranked #684.

Canada Life first reported a position in EHC in Q4 2013 and has held it in 50 quarters since. The position peaked at $9.47M in Q3 2025. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Canada Life held 59,820 shares of Encompass Health worth $5.79M as of Q1 2026.
  • Canada Life sold 178 Encompass Health shares in Q1 2026, an estimated $18.3K.
  • Encompass Health made up 0.01% of Canada Life's portfolio in Q1 2026, its #684 holding.
  • Canada Life first reported a position in Encompass Health in Q4 2013 and has held it in 50 quarters since.
  • Canada Life's Encompass Health position peaked at $9.47M in Q3 2025.
  • 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.